Stay updated with breaking news from Johnson Amp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PFS Partners LLC lowered its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 7.3% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,225 shares of the company’s stock after selling 97 shares during the quarter. PFS Partners LLC’s holdings in Johnson […]
B. Riley Wealth Advisors Inc. lessened its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 148,486 shares of the company’s stock after selling 817 shares during the quarter. Johnson & Johnson […]
/PRNewswire/ -- Johnson & Johnson today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
The submission could grant guselkumab its third indication, after being approved by the FDA for psoriasis and psoriatic arthritis.
A $10 million investment is aiming to reduce drug-related overdose deaths and overdose racial disparities in Michigan.